Danaher Corporation (DHR)
NYSE: DHRIndustrialsIndustrial Machinery/ComponentsUSD
At close: Nov 20, 4:02 PM ET · Delayed 15 min
DHR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $155.03B
- P/E (TTM)
- 36.48
- Forward P/E
- 23.64
- EPS (TTM)
- $6.04
- Dividend yield
- 0.69% ($1.52)
- Ex-dividend date
- Sep 30, 2026
- 52-week range
- 160.93 – 242.80
- Day range
- 219.93 – 228.10
- Volume / Avg
- 3.99M / 3.99M
- Beta
- —
- Shares outstanding
- 703.53M
52-week range
DHR stock today
Danaher (DHR) closed at $220.36 on Nov 20, down 3.16% (-$7.20), versus the S&P 500's 3.70% decline. At this level, DHR sits in the middle of its 52-week range of $160.93 to $242.80: 9.2% below the high, set on Jan 22, 2026 and 36.9% above the low. DHR is down 3.7% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 3.1%.
At 36.5x trailing earnings, Danaher trades above the peer-group median of 29.3x. Its forward P/E of 23.6x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Danaher pays an annual dividend of $1.52 per share, a 0.69% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Danaher
Company profileDanaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions.
- Sector
- Industrials
- Industry
- Industrial Machinery/Components
- CEO
- Ms. Julie Sawyer Montgomery
- Headquarters
- Washington, DC
- Employees
- 58,000
- Website
- danaher.com
Financial highlights
Full financialsIn fiscal 2025, Danaher generated $24.57 billion in revenue, up 2.9% from fiscal 2024. Net income was $3.61 billion (-7.3% year over year), for a net margin of 14.7% versus a median of 19.9% in the prior 5 years. Gross margin was 59.1% (down from 59.5%) and operating margin 19.1%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B |
| Growth | +2.90% | -0.06% | -10.33% | +7.42% | +11.30% |
| Net income | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B |
| EPS (diluted) | $5.05 | $5.29 | $6.38 | $9.66 | $8.61 |
Analyst forecast
ForecastConsensus (24 analysts)
strong_buy
Avg. price target
$259.90+17.94%
- Strong buy 3
- Buy 17
- Hold 4
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Oct 21, 2026
- EPS actual vs est.
- $1.75 vs $1.92
- Surprise
- -8.85%
Dividends
Dividend history- Annual dividend
- $1.52
- Dividend yield
- 0.69%
- Last payment
- $0.40
- Ex-dividend date
- Sep 30, 2026
DHR news
All DHR news- Danaher Partners With Microsoft For AI-powered Ecosystem Involving Scientific InstrumentsNasdaqDHR, MSFT
- Danaher (DHR) Down 1% Since Last Earnings Report: Can It Rebound?Nasdaq
- Danaher Collaborates with Microsoft to Make Scientific Instruments Agentically Connected and Laboratories More IntelligentPR NewswireDHR, MSFT
- Danaher Targets Faster Growth With Acquisitions, AI and a Diagnostics PushNasdaq
- Danaher Corporation (DHR) Presents at Jefferies Global Healthcare Conference 2026 TranscriptSeeking Alpha
- VTRS or DHR: Which Is the Better Value Stock Right Now?NasdaqVTRS, DHR
- Danaher CEO Sees Faster Growth Ahead, With AI and Acquisitions in FocusNasdaq
- Danaher Corporation (DHR) Presents at 2026 UBS Global Healthcare Conference TranscriptSeeking Alpha
Danaher peers
Industrials sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| DEDeere & Company | 609.25 | -2.50% | $164.27B | vs DHR |
| ETNEaton Corporation PLC | 311.33 | -5.82% | $120.95B | vs DHR |
| LRCXLam Research Corporation | 183.27 | -10.02% | $228.94B | vs DHR |
| JCIJohnson Controls International plc | 130.18 | -4.28% | $78.13B | vs DHR |
| ITWIllinois Tool Works Inc. | 273.57 | -1.20% | $77.75B | vs DHR |
| NOCNorthrop Grumman Corporation | 534.31 | -1.48% | $75.91B | vs DHR |
| VRTVertiv Holdings LLC Class A | 166.24 | -10.14% | $64.01B | vs DHR |
| TMOThermo Fisher Scientific Inc | 669.54 | -2.79% | $248.08B | vs DHR |
Indexes, lists and sector
Index membership
Appears in lists
Danaher stock FAQ
What is Danaher's stock price today?
DHR last traded at $220.36 as of Nov 20, 4:02 PM EST, down 3.16% on the day. Prices are delayed at least 15 minutes.
Does Danaher pay a dividend?
Yes. Danaher pays $1.52 per share annually, a 0.69% yield. The most recent dividend of $0.40 had an ex-dividend date of Sep 30, 2026.
What is DHR's P/E ratio?
DHR trades at a trailing P/E ratio of 36.48 and a forward P/E of 23.64, compared with a median of 29.3 for its closest peers.
Is Danaher in the S&P 500?
Yes. Danaher (DHR) is a constituent of the S&P 500 index.
Who is Danaher's CEO?
Ms. Julie Sawyer Montgomery is the chief executive officer of Danaher Corporation, which has about 58,000 employees.
Has DHR ever split its stock?
Yes. The most recent DHR stock split was a 1128-for-1000 split on Oct 2, 2023, one of 7 splits on record.
What is the DHR 52-week high?
The 52-week high for DHR is $242.80 and the 52-week low is $160.93. The stock is currently 9.2% below its high.